Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Shenzhen Vital New Material
301319
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.55%10.7B | 1.50%2.7B | 4.99%2.72B | 4.20%2.67B | 3.56%2.61B | 3.80%10.33B | 4.12%2.66B | 3.78%2.59B | 2.53%2.56B | 4.82%2.52B |
Operating revenue | 3.55%10.7B | 1.50%2.7B | 4.99%2.72B | 4.20%2.67B | 3.56%2.61B | 3.80%10.33B | 4.12%2.66B | 3.78%2.59B | 2.53%2.56B | 4.82%2.52B |
Cost of revenue | 3.32%8.48B | 1.44%2.12B | 5.27%2.16B | 4.06%2.13B | 2.55%2.08B | 0.98%8.21B | -2.69%2.09B | 3.48%2.05B | 3.88%2.04B | -0.39%2.03B |
Gross profit | 4.42%2.22B | 1.73%579.77M | 3.94%559.71M | 4.76%544.15M | 7.69%535.53M | 16.36%2.13B | 39.99%569.92M | 4.91%538.5M | -2.46%519.43M | 33.17%497.31M |
Operating expense | 5.64%1.92B | 5.59%484.84M | 6.88%485.53M | 3.75%474.58M | 6.34%478.16M | 17.48%1.82B | 6.23%459.16M | 5.68%454.26M | 9.19%457.43M | 67.42%449.64M |
Selling and administrative expenses | 5.31%1.91B | 7.84%493.07M | 3.80%469.8M | 3.14%469.31M | 6.44%477.61M | 16.64%1.81B | 5.72%457.23M | 5.02%452.58M | 7.85%455.03M | 66.52%448.72M |
Other operating expenses | 92.15%13.32M | -524.24%-8.23M | 837.81%15.73M | 119.57%5.26M | -39.85%551K | 231.95%6.93M | 935.78%1.94M | 249.07%1.68M | 180.03%2.4M | 201.89%916K |
Operating profit | -2.83%296.05M | -14.30%94.93M | -11.94%74.18M | 12.21%69.58M | 20.34%57.37M | 10.08%304.67M | 540.97%110.76M | 0.95%84.24M | -45.41%62.01M | -54.55%47.67M |
Net non-operating interest income expense | 8.94%-143.8M | 3.16%-35.7M | 4.13%-36.55M | 11.86%-35.9M | 15.51%-35.66M | -22.52%-157.92M | 10.45%-36.86M | 4.37%-38.13M | -13.64%-40.73M | -251.09%-42.2M |
Non-operating interest expense | -8.94%143.8M | -3.16%35.7M | -4.13%36.55M | -11.86%35.9M | -15.51%35.66M | 22.52%157.92M | -10.45%36.86M | -4.37%38.13M | 13.64%40.73M | 251.09%42.2M |
Other net income (expense) | -152.93%-509.6M | -578.41%-358.88M | 9.95%-51.42M | 3.36%-50.48M | -24.39%-48.82M | -47.07%-201.48M | -81.50%-52.9M | -138.06%-57.1M | -33.01%-52.24M | 12.00%-39.25M |
Special income (charges) | -156.76%-504.92M | -658.14%-357.99M | 17.25%-49.98M | 3.69%-49.28M | -25.90%-47.67M | -46.89%-196.65M | -66.49%-47.22M | -160.33%-60.4M | -32.93%-51.17M | 13.59%-37.86M |
-Less:Restructuring and merger&acquisition | -1.73%196.71M | -1.89%49.78M | -17.25%49.98M | -3.69%49.28M | 25.90%47.67M | 49.52%200.16M | 78.89%50.74M | 160.33%60.4M | 32.93%51.17M | -13.59%37.86M |
-Less:Impairment of capital assets | --307.11M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Other special charges | 131.30%1.1M | ---- | ---- | ---- | ---- | ---3.52M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 3.18%-4.68M | 84.38%-887K | -143.55%-1.44M | -12.41%-1.21M | 16.87%-1.15M | -54.49%-4.84M | -624.49%-5.68M | 521.71%3.3M | -36.91%-1.07M | -77.14%-1.39M |
Income before tax | -552.99%-357.36M | -1,527.11%-299.65M | -25.53%-13.79M | 45.72%-16.81M | 19.73%-27.11M | -602.49%-54.73M | 122.00%21M | -156.06%-10.98M | -180.50%-30.96M | -170.00%-33.78M |
Income tax | 139.69%5.33M | -210.02%-3.54M | 77.67%-1.02M | 655.44%15.11M | 44.17%-5.23M | -16.76%-13.43M | 108.58%3.21M | -164.22%-4.56M | -127.59%-2.72M | -204.25%-9.36M |
Net income | -778.15%-362.69M | -1,765.07%-296.12M | -98.72%-12.77M | -13.00%-31.91M | 10.37%-21.89M | -284.47%-41.3M | 130.67%17.78M | -151.42%-6.43M | -198.73%-28.24M | -162.17%-24.42M |
Net income continuous Operations | -778.15%-362.69M | -1,765.07%-296.12M | -98.72%-12.77M | -13.00%-31.91M | 10.37%-21.89M | -284.47%-41.3M | 130.67%17.78M | -151.42%-6.43M | -198.73%-28.24M | -162.17%-24.42M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -778.15%-362.69M | -1,765.07%-296.12M | -98.72%-12.77M | -13.00%-31.91M | 10.37%-21.89M | -284.47%-41.3M | 130.67%17.78M | -151.42%-6.43M | -198.73%-28.24M | -162.17%-24.42M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -778.15%-362.69M | -1,765.07%-296.12M | -98.72%-12.77M | -13.00%-31.91M | 10.37%-21.89M | -284.47%-41.3M | 130.67%17.78M | -151.42%-6.43M | -198.73%-28.24M | -162.17%-24.42M |
Basic earnings per share | -775.93%-4.73 | -1,769.57%-3.84 | -112.50%-0.17 | -13.51%-0.42 | 9.38%-0.29 | -280.00%-0.54 | 129.87%0.23 | -147.06%-0.08 | -197.37%-0.37 | -160.38%-0.32 |
Diluted earnings per share | -775.93%-4.73 | -1,769.57%-3.84 | -112.50%-0.17 | -13.51%-0.42 | 9.38%-0.29 | -286.21%-0.54 | 129.87%0.23 | -150.00%-0.08 | -200.00%-0.37 | -161.54%-0.32 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |